Meloxicam 7.5 MG Oral Tablet — RxCUI 311486
RxNorm drug concept · Semantic clinical drug
RxCUI 311486
Semantic clinical drug · SCD
● Current RxNorm concept 89 FDA products
336 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311486
Official nameMeloxicam 7.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped89
Package NDCs mapped336
Reported Medicaid activity (SDUD)3,309,965 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Meloxicam is primarily used to relieve pain and inflammation caused by osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis in kids. There are also two IV versio...
- What exactly is meloxicam used for — is it just for arthritis?
- Good news — you can take oral meloxicam with or without food, so it fits into your routine however works best for you. If your stomach tends to be sensitive, taking it with a littl...
- Should I take meloxicam with food, or does it not matter?
🕸️ Concept Web — How Meloxicam 7.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Meloxicam 7.5 MG Oral Tablet
RxCUI 311486 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Meloxicam
41493IN
-
Meloxicam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mobic
152699BN
-
Mobic
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Meloxicam Oral Tablet
372754SCDF -
Meloxicam Oral Product
1165678SCDG -
Meloxicam Pill
1165679SCDG -
Meloxicam Oral Tablet [Mobic]
368154SBDF -
Mobic Oral Product
1181062SBDG -
Mobic Pill
1181063SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Meloxicam Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Meloxicam 7.5 MG
323968SCDC -
Meloxicam 7.5 MG Oral Tablet [Mobic]
152697SBD -
Meloxicam 7.5 MG [Mobic]
565025SBDC
-
Meloxicam 7.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Meloxicam 7.5 MG
SCDC · 323968 -
Meloxicam Oral Tablet
SCDF · 372754 -
Meloxicam Oral Product
SCDG · 1165678 -
Meloxicam Pill
SCDG · 1165679
Brand-Name Concepts
-
Meloxicam 7.5 MG Oral Tablet [Mobic]
SBD · 152697 -
Meloxicam 7.5 MG [Mobic]
SBDC · 565025 -
Meloxicam Oral Tablet [Mobic]
SBDF · 368154 -
Mobic Oral Product
SBDG · 1181062 -
Mobic Pill
SBDG · 1181063 -
Mobic
BN · 152699
📦 FDA Products & Package NDCs
89 products · 336 package NDCs
336 package NDCs map to RxCUI 311486 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 80425-0041-03 | 90 TABLET in 1 BOTTLE (80425-0041-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2007-03-07 |
| 80425-0041-04 | 6 TABLET in 1 BOTTLE (80425-0041-4) | Meloxicam | Advanced Rx of Tennessee, LLC | 2007-03-07 |
| 80425-0042-01 | 30 TABLET in 1 BOTTLE (80425-0042-1) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0042-02 | 60 TABLET in 1 BOTTLE (80425-0042-2) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0042-03 | 90 TABLET in 1 BOTTLE (80425-0042-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0043-01 | 30 TABLET in 1 BOTTLE (80425-0043-1) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0043-02 | 60 TABLET in 1 BOTTLE (80425-0043-2) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0043-03 | 90 TABLET in 1 BOTTLE (80425-0043-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2006-07-19 |
| 80425-0558-01 | 30 TABLET in 1 BOTTLE (80425-0558-1) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0558-02 | 60 TABLET in 1 BOTTLE (80425-0558-2) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0558-03 | 90 TABLET in 1 BOTTLE (80425-0558-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0558-04 | 120 TABLET in 1 BOTTLE (80425-0558-4) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0559-01 | 30 TABLET in 1 BOTTLE (80425-0559-1) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0559-02 | 60 TABLET in 1 BOTTLE (80425-0559-2) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0559-03 | 90 TABLET in 1 BOTTLE (80425-0559-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0559-04 | 120 TABLET in 1 BOTTLE (80425-0559-4) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-11-24 |
| 80425-0563-01 | 30 TABLET in 1 BOTTLE (80425-0563-1) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-12-05 |
| 80425-0563-02 | 60 TABLET in 1 BOTTLE (80425-0563-2) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-12-05 |
| 80425-0563-03 | 90 TABLET in 1 BOTTLE (80425-0563-3) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-12-05 |
| 80425-0563-04 | 120 TABLET in 1 BOTTLE (80425-0563-4) | Meloxicam | Advanced Rx of Tennessee, LLC | 2025-12-05 |
| 82009-0129-05 | 500 TABLET in 1 BOTTLE (82009-129-05) | meloxicam | Quallent Pharmaceuticals Health LLC | 2023-08-03 |
| 82009-0130-05 | 500 TABLET in 1 BOTTLE (82009-130-05) | meloxicam | Quallent Pharmaceuticals Health LLC | 2023-08-03 |
| 82461-0712-30 | 30 TABLET in 1 BOTTLE (82461-712-30) | MELOXICAM | Medcore LLC | 2025-10-30 |
| 82461-0719-30 | 30 TABLET in 1 BOTTLE (82461-719-30) | MELOXICAM | Medcore LLC | 2026-03-25 |
| 85509-1124-01 | 100 TABLET in 1 BOTTLE (85509-1124-1) | meloxicam | PHOENIX RX LLC | 2025-11-14 |
| 85509-1124-03 | 30 TABLET in 1 BOTTLE (85509-1124-3) | meloxicam | PHOENIX RX LLC | 2025-11-14 |
| 85509-1124-06 | 60 TABLET in 1 BOTTLE (85509-1124-6) | meloxicam | PHOENIX RX LLC | 2025-11-14 |
| 85509-1124-09 | 90 TABLET in 1 BOTTLE (85509-1124-9) | meloxicam | PHOENIX RX LLC | 2025-11-14 |
| 85534-0019-00 | 30 TABLET in 1 BOTTLE (85534-0019-0) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0019-01 | 60 TABLET in 1 BOTTLE (85534-0019-1) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0019-02 | 90 TABLET in 1 BOTTLE (85534-0019-2) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0019-03 | 120 TABLET in 1 BOTTLE (85534-0019-3) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0020-00 | 30 TABLET in 1 BOTTLE (85534-0020-0) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0020-01 | 60 TABLET in 1 BOTTLE (85534-0020-1) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0020-02 | 90 TABLET in 1 BOTTLE (85534-0020-2) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
| 85534-0020-03 | 120 TABLET in 1 BOTTLE (85534-0020-3) | meloxicam | HAWAII REPACK, INC. | 2026-06-25 |
Observed labelers:
Proficient Rx LP (37) ·
Bryant Ranch Prepack (33) ·
PD-Rx Pharmaceuticals, Inc. (23) ·
Advanced Rx of Tennessee, LLC (22) ·
Asclemed USA, Inc. (18) ·
Terrain Pharmaceuticals, Inc. (14)
· +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.